During the past decade, Evanston Northwestern Healthcare conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Evanston Northwestern Healthcare" #1 sponsor was "University of Chicago" with 13 trials, followed by "National Cancer Institute (NCI)" with 4 trials sponsored, "Abbott" with 3 trials sponsored, "Abbott Medical Devices" with 3 trials sponsored and "Celtic Pharma Development Services" with 3 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Evanston Northwestern Healthcare" #1 collaborator was "National Cancer Institute (NCI)" with 18 trials as a collaborator, "Neurobiological Technologies" with 3 trials as a collaborator, "Children's Hospital Medical Center, Cincinnati" with 2 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Evanston Northwestern Healthcare" are "Head and Neck Cancer" (5 trials), "Lung Cancer" (5 trials), "Colorectal Cancer" (4 trials), "Brain Edema" (3 trials) and "Brain Tumor" (3 trials). Many other conditions were trialed in "Evanston Northwestern Healthcare" in a lesser frequency.

Most popular intervention types in "Evanston Northwestern Healthcare" are "Drug" (49 trials), "Procedure" (10 trials), "Device" (7 trials), "Biological" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "oxaliplatin" (5 trials), "paclitaxel" (3 trials), "semaxanib" (3 trials), "Darusentan" (2 trials) and "O6-benzylguanine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Evanston Northwestern Healthcare" are 55 trials for "All" genders, 5 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Evanston Northwestern Healthcare". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 49 completed trials in Evanston Northwestern Healthcare, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Evanston Northwestern Healthcare, 4 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".